Bain Capital Life Sciences Investors, LLC: holdings and changes
Number 58 of the top 100 funds by copy return. Bain Capital Life Sciences Investors, LLC reported 23 US stocks worth $1.5B for the quarter ending 2026-09-30 and changed 4 new, 2 added, 3 trimmed and 2 sold since 2026-06-30.
Copy return, 4 quarters+44.6%
US 500, same time+14.5%
Size$1.5B
Stocks23
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| KLRA Kailera Therapeutics INC | 17.29% | $258M | 22,583,268 | |
| HTFL Heartflow INC | TRIM -47% | 14.84% | $221M | 4,448,158 |
| ADRX Adarx Pharmaceuticals INC | BUY | 9.00% | $134M | 6,728,970 |
| ALKS Alkermes PLC | ADD +63% | 8.56% | $128M | 3,150,985 |
| NAMS Newamsterdam Pharma Company | 6.21% | $93M | 3,806,559 | |
| SVRA Savara INC | 6.09% | $91M | 17,600,621 | |
| TARS Tarsus Pharmaceuticals INC | BUY | 5.78% | $86M | 1,096,141 |
| PHVS Pharvaris N V | TRIM -7% | 5.26% | $78M | 2,475,509 |
| SLDB Solid Biosciences INC | 4.75% | $71M | 9,808,819 | |
| OLEMA PHARMACE Olema Pharmaceut | 4.10% | $61M | 7,085,249 | |
| COAG Hemab Therapeutics Hldgs INC | 3.41% | $51M | 1,650,000 | |
| CABA Cabaletta Bio INC | ADD +23% | 2.73% | $41M | 21,209,188 |
| FRNM Freenome INC | BUY | 2.50% | $37M | 2,365,459 |
| DYN Dyne Therapeutics INC | BUY | 2.05% | $31M | 1,900,000 |
| CCCC C4 Therapeutics INC | 1.60% | $24M | 7,171,910 | |
| XFOR X4 Pharmaceuticals INC Com New | 1.55% | $23M | 7,967,454 | |
| ANNX Annexon INC | 1.26% | $19M | 4,437,731 | |
| AVIR Atea Pharmaceuticals INC | 0.73% | $11M | 2,075,639 | |
| IRON Disc Medicine INC | 0.62% | $9M | 141,234 | |
| KYTX Kyverna Thera INC | TRIM -55% | 0.60% | $9M | 1,312,000 |
| RPID Rapid Micro Biosystems INC | 0.58% | $9M | 8,434,560 | |
| XLO Xilio Therapeutics INC | 0.40% | $6M | 664,021 | |
| NAMS Newamsterdam Pharma Company | 0.08% | $1M | 99,999 | |
| DNTH Dianthus Therapeutics INC | SELL | 0% | was $35M | 0 |
| UPB Upstream Bio INC | SELL | 0% | was $4M | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-09-30 → 2023-12-31 | +36.0% | +11.2% |
| 2023-12-31 → 2024-03-31 | +26.7% | +10.0% |
| 2024-03-31 → 2024-06-30 | -13.1% | +4.0% |
| 2024-06-30 → 2024-09-30 | +2.5% | +5.4% |
| 2024-09-30 → 2024-12-31 | +0.6% | +2.1% |
| 2024-12-31 → 2025-03-31 | -19.9% | -4.6% |
| 2025-03-31 → 2025-06-30 | +10.4% | +10.5% |
| 2025-06-30 → 2025-09-30 | +50.1% | +7.8% |
| 2025-09-30 → 2025-12-31 | +42.1% | +2.4% |
| 2025-12-31 → 2026-03-31 | -4.5% | -4.6% |
| 2026-03-31 → 2026-06-30 | +9.0% | +14.8% |
| 2026-06-30 → 2026-09-30 | -2.3% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP